Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 7,945-7,956 of 10,592

Drug study icon

CompletedNCT05631626

Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.

This study is completed in the United States. It focuses on ADHD.

Remote / online

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Cingulate Therapeutics
Condition: ADHD

Drug study icon

Enrolling By InvitationNCT07095465

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

This study is enrolling by invitation in the United States, in Bulgaria, and in Czechia. It is testing ACP-204 for Schizophrenia.

In United States

SchizophreniaDrugFrom 55 Years to 84 Years

Countries: United States, Bulgaria, Czechia
Sponsor: ACADIA Pharmaceuticals Inc.
Condition: Schizophrenia

Drug study icon

TerminatedNCT03143543

Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Addiction and Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Virginia Commonwealth University
Condition: Addiction

Drug study icon

CompletedNCT02286817

NFC-1 for ADHD

This study is completed in the United States. It is testing NFC-1 for ADHD.

In United States

ADHDDrugFrom 12 Years to 17 Years

Countries: United States
Sponsor: Aevi Genomic Medicine, LLC, a Cerecor company
Condition: ADHD

Device study icon

TerminatedNCT01851603

Safety study of Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Schizophrenia

This study was terminated in the United States. It is testing Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 for Schizophrenia.

In United States

SchizophreniaDeviceFrom 18 Years to 70 Years

Countries: United States
Sponsor: University of Colorado, Denver
Condition: Schizophrenia

Behavioral study icon

CompletedNCT01672684

Phase I: At-Home Support for Rural Women Using Group Video Calling

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, DepressionBehavioralOver 21 Years

Countries: United States
Sponsor: Stanford University
Condition: PTSD, Depression

Behavioral study icon

CompletedNCT05976646

Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Virginia Commonwealth University
Condition: Addiction

Other study type icon

CompletedNCT00365209

Phase II A study of Curcumin Among people with Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionOtherOver 40 Years

Countries: United States
Sponsor: National Cancer Institute (NCI)
Condition: Addiction

Behavioral study icon

Active Not RecruitingNCT04806516

Phase II Adaptive Deep Brain Stimulation for OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 18 Years to 70 Years

Countries: United States
Sponsor: Baylor College of Medicine
Condition: OCD

Behavioral study icon

CompletedNCT02264327

Phase II Motivational Interviewing: An Experiential Online Training Tool

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

AddictionBehavioralFrom 21 Years to 70 Years

Countries: United States
Sponsor: Center for Social Innovation, Massachusetts
Condition: Addiction

Drug study icon

CompletedNCT02710526

Phase II Pharmacokinetics Study of CAM2038

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 19 Years to 65 Years

Countries: United States
Sponsor: Braeburn Pharmaceuticals
Condition: Addiction

Drug study icon

CompletedNCT02933606

Phase II Study of BNC210 in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 70 Years

Countries: United States, Australia
Sponsor: Bionomics Limited
Condition: PTSD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.